USP General Chapter <800> Compliance Toolkit and Resources for Psychiatric Facilities

The CPNP USP <800> Compliance Toolkit includes assessments of risk on the formulations listed below. To request additional formulations, simply email the CPNP Office, and they will be considered.

  1. Abacavir, Solution
  2. Abacavir, Tablet
  3. Abacavir/Dolutegravir/Lamivudine, Tablet
  4. Abacavir/Lamivudine, Tablet
  5. Abacavir/Lamivudine/Zidovudine, Tablet
  6. Acitretin, Capsule
  7. Anastrozole, Tablet
  8. Azathioprine, Injection
  9. Azathioprine, Tablet
  10. Cabergoline, Tablet
  11. Carbamazepine, Capsule, XR
  12. Carbamazepine, Suspension
  13. Carbamazepine, Tablet
  14. Carbamazepine, Tablet, Chew
  15. Carbamazepine, Tablet, XR
  16. Clonazepam, Oral Disintegrating Tablet
  17. Clonazepam, Tablet
  18. Colchicine, Capsule
  19. Colchicine, Tablet
  20. Cyclosporine, Capsule
  21. Cyclosporine, Ophthalmic
  22. Cyclosporine, Solution
  23. Dinoprostone, Vaginal Suppository
  24. Divalproex, Sprinkles
  25. Divalproex, Tablet DR & ER
  26. Dronedarone, Tablet
  27. Dutasteride, Capsule
  28. Entecavir, Solution
  29. Entecavir, Tablet
  30. Estradiol, Gel
  31. Estradiol, Patch
  32. Estradiol, Spray, Topical
  33. Estradiol, Tablet
  34. Estradiol, Vaginal Cream
  35. Estradiol, Vaginal Insert
  36. Estrogen/Progestin Combinations, Patch
  37. Estrogen/Progestin Combinations, Tablet
  38. Estrogens, Conjugated, Injection
  39. Estrogens, Conjugated, Tablet
  40. Estrogens, Conjugated, Vaginal Cream
  41. Estropipate, Tablet
  42. Finasteride, Tablet
  43. Fluconazole, IV
  44. Fluconazole, Suspension
  45. Fluconazole, Tablet
  46. Fluorouracil, Cream
  47. Fluorouracil, Solution, Topical
  48. Flutamide, Capsule
  49. Fosphenytoin, IV
  50. Leflunomide, Tablet
  51. Letrozole, Tablet
  52. Liraglutide Recombinant, Injection
  53. Medroxyprogesterone, Injection
  54. Medroxyprogesterone, Tablet
  55. Megestrol, Liquid
  56. Megestrol, Tablet
  57. Methimazole, Tablet
  58. Methotrexate, Solution
  59. Methotrexate, Tablet
  60. Misoprostol, Tablet
  61. Mycophenolate Mofetil, IV
  62. Mycophenolate Mofetil, Liquid
  63. Mycophenolate Mofetil, Tablet/Capsule
  64. Mycophenolic Acid, Tablet
  65. Nevirapine, Suspension
  66. Nevirapine, Tablet
  67. Nevirapine, Tablet ER
  68. Oxcarbazepine, Suspension
  69. Oxcarbazepine, Tablet
  70. Paroxetine, Suspension
  71. Paroxetine, Tablet
  72. Paroxetine, Tablet ER
  73. Phenytoin, Capsule
  74. Phenytoin, Suspension
  75. Phenytoin, Tablet, Chew
  76. Progesterone, Capsule
  77. Progesterone, Injection
  78. Progesterone, Vaginal Insert & Suppository
  79. Propylthiouracil, Tablet
  80. Raloxifene, Tablet
  81. Ribavirin, Capsule
  82. Ribavirin, Solution
  83. Ribavirin, Tablet
  84. Sirolimus, Solution
  85. Sirolimus, Tablet
  86. Sorafenib, Tablet
  87. Spironolactone, Tablet
  88. Tacrolimus, Capsule
  89. Tacrolimus, Capsule XR/Tablet XR
  90. Tacrolimus, Ointment
  91. Tamoxifen, Solution
  92. Tamoxifen, Tablet
  93. Temazepam, Capsule
  94. Testosterone, Buccal Tablet
  95. Testosterone, Gel/Jelly
  96. Testosterone, Injection
  97. Testosterone, Patch
  98. Testosterone, Solution, Topical
  99. Testosterone, Spray, Topical
  100. Thalidomide, Capsule
  101. Topiramate, Capsule ER/Tablet ER
  102. Topiramate, Sprinkle
  103. Tretinoin, Capsule
  104. Tretinoin, Gel/Jelly/Cream
  105. Valganciclovir, Solution
  106. Valganciclovir, Tablet
  107. Valproic Acid/Valproate, Capsule
  108. Valproic Acid/Valproate, Injection
  109. Valproic Acid/Valproate, Suspension
  110. Vigabatrin, Packet, Oral
  111. Vigabatrin, Tablet
  112. Voriconazole, Injection
  113. Voriconazole, Suspension
  114. Voriconazole, Tablet
  115. Warfarin, Tablet
  116. Zidovudine, Capsule
  117. Zidovudine, IV
  118. Zidovudine, Syrup
  119. Zidovudine, Tablet
  120. Ziprasidone, Capsule
  121. Ziprasidone, Injection
  122. Zoledronic Acid, IV
  123. Zonisamide, Capsule

Formulations with Pending Assessments of Risk

The following formulations are currently being assessed and will be added to the toolkit in 2019. To request additional formulations, simply email the CPNP Office, and they will be considered.

  1. Capecitabine, Tablet
  2. Clobazam, Tablet and suspension 
  3. Exemestane, Tablet
  4. Exenatide, SQ Injection
  5. Hydroxyurea, Capsule
  6. Hydroxyurea, Tablet
  7. Imatinib, Tablet
  8. Interferon Beta 1-b, SQ injection 
  9. Isotretinoin, Capsule
  10. Mercaptopurine, Tablet and Suspension
  11. Rasagiline, Tablet
  12. Triazolam, Tablet

Removed Formulations

The following formulations have been removed from the toolkit due to a change of designation that excludes them from the USP <800> compliance process.